CLRN1 Gene

CLRN1 Gene

Gene Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CLRN1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>CLRN1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Clarin 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3p21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td>[55630](https://www.ncbi.nlm.nih.gov/gene/55630)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[606397](https://www.omim.org/entry/606397)</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>[ENSG00000122218](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000122218)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9NYQ5](https://www.uniprot.org/uniprot/Q9NYQ5)</td>
</tr>
</table>

{{.infobox .infobox-gene}}

Associated Diseases

Usher syndrome type 3A, Sensorineural hearing loss, Retinitis pigmentosa

Function

CLRN1 encodes clarin 1, a member of the tetraspanin family of proteins, which are characterized by four transmembrane domains. Clarin 1 is essential for the formation and maintenance of stereocilia in inner ear hair cells and for photoreceptor cell function [1](https://pubmed.ncbi.nlm.nih.gov/12552872/).

Molecular Function

Clarin 1 localizes to the plasma membrane of hair cell stereocilia and photoreceptor cells. The protein forms oligomeric complexes and interacts with other Usher syndrome proteins including:

...

CLRN1 Gene

Gene Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CLRN1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>CLRN1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Clarin 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3p21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td>[55630](https://www.ncbi.nlm.nih.gov/gene/55630)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[606397](https://www.omim.org/entry/606397)</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>[ENSG00000122218](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000122218)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9NYQ5](https://www.uniprot.org/uniprot/Q9NYQ5)</td>
</tr>
</table>

{{.infobox .infobox-gene}}

Associated Diseases

Usher syndrome type 3A, Sensorineural hearing loss, Retinitis pigmentosa

Function

CLRN1 encodes clarin 1, a member of the tetraspanin family of proteins, which are characterized by four transmembrane domains. Clarin 1 is essential for the formation and maintenance of stereocilia in inner ear hair cells and for photoreceptor cell function [1](https://pubmed.ncbi.nlm.nih.gov/12552872/).

Molecular Function

Clarin 1 localizes to the plasma membrane of hair cell stereocilia and photoreceptor cells. The protein forms oligomeric complexes and interacts with other Usher syndrome proteins including:

• Whirlin (WHRN) - scaffolding protein at stereocilia tips
• VLGR1 (GPR98) - involved in ankle link formation
• Myosin VIIa - motor protein for intracellular transport
• Sans (USH1G) - scaffold protein in the USH1 complex

The exact signaling pathway of clarin 1 remains under investigation, but it appears to function in organizing the protein complexes necessary for stereocilia bundle formation and maintenance [2](https://pubmed.ncbi.nlm.nih.gov/14638761/).

Tetraspanin Function

As a tetraspanin, clarin 1 likely participates in:

• Membrane microdomain organization - tetraspanins organize lipid rafts
• Protein complex scaffolding - bring together signaling components
• Membrane trafficking - regulate vesicle fusion and protein delivery

Expression

Tissue Distribution

CLRN1 is expressed primarily in:

• Inner ear: Hair cells of the cochlea and vestibular system
• Retina: Photoreceptor cells (rods and cones)
• Brain: Lower expression in cerebellum and [cortex](/brain-regions/cortex)
• Kidney: Lower expression

Developmental Expression

The protein is expressed throughout development, with particular importance during late embryonic and early postnatal periods when stereocilia bundles mature.

Clinical Significance

Usher Syndrome Type 3A

Mutations in CLRN1 cause Usher syndrome type 3A, characterized by:

• Progressive hearing loss (typically post-lingual, beginning in adolescence)
• Variable vestibular function (may be normal or reduced)
• Progressive retinitis pigmentosa (night blindness beginning in adolescence)

The phenotype is variable, and some mutations may cause isolated hearing loss without retinal involvement.

Genotype-Phenotype Correlations

• Missense mutations: Often associated with milder phenotype
• Nonsense/frameshift mutations: Typically cause classic Usher type 3A
• Certain mutations: May cause isolated retinal degeneration without hearing loss

Neurodegeneration Connections

Hair Cell Degeneration

CLRN1 mutations lead to progressive degeneration of hair cells, representing a model of sensory neuron degeneration:

Stereocilia degeneration - initial pathology visible as disorganization

Hair cell death - followed by progressive loss

Auditory nerve degeneration - secondary to hair cell loss

Understanding these mechanisms may inform:

• Age-related hearing loss - shared degenerative pathways
• Noise-induced hearing loss - stereocilia damage mechanisms
• Ototoxic drug effects - aminoglycoside-induced hair cell death

Retinal Degeneration

The photoreceptor degeneration in Usher syndrome type 3A shares features with:

• Retinitis pigmentosa (non-syndromic forms)
• Age-related macular degeneration - some shared pathways
• Photoreceptor dystrophies - common mechanisms of cell death

Key Publications

[Identification of CLRN1 as the USH3A gene (2003)](https://pubmed.ncbi.nlm.nih.gov/12552872/)

[Clarin 1 function in hair cells (2004)](https://pubmed.ncbi.nlm.nih.gov/14638761/)

[Clinical phenotype of USH3A (2006)](https://pubmed.ncbi.nlm.nih.gov/16679485/)

[Clarin 1 knockout mouse model (2010)](https://pubmed.ncbi.nlm.nih.gov/20386745/)

[Gene therapy for USH3A (2018)](https://pubmed.ncbi.nlm.nih.gov/29958542/)

See Also

• [Usher syndrome](/diseases/usher-syndrome)
• [Hair cell proteins](/categories/hair-cells)
• [Tetraspanin proteins](/categories/tetraspanins)
• [Retinitis pigmentosa](/diseases/retinitis-pigmentosa)
• [Sensory genes](/categories/sensory-genes)

External Links

• [NCBI Gene: CLRN1](https://www.ncbi.nlm.nih.gov/gene/55630)
• [UniProt: Q9NYQ5](https://www.uniprot.org/uniprot/Q9NYQ5)
• [Ensembl: ENSG00000122218](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000122218)
• [OMIM: 606397](https://www.omim.org/entry/606397)

Protein Structure

Tetraspanin Architecture

Clarin 1 is a tetraspanin with characteristic features:

• [Four transmembrane domains*: Position 60-82, 120-142, 170-192, 205-227](/genes/ran)
• [Small extracellular loops*: Between TM1-TM2 and TM3-TM4](/genes/ar)
• [Large extracellular loop (EC2)*: Major functional domain (~100 aa)](/genes/ar)
• N- and C-terminal cytoplasmic tails: Short cytoplasmic regions

The large extracellular loop (EC2) contains:

• Conserved cysteine residues: Form disulfide bonds
• N-glycosylation sites: For protein folding and trafficking
• Protein interaction motifs: For partner binding

Oligomerization

Clarin 1 forms homooligomers and heterooligomers with other tetraspanins, which may be important for its function in membrane microdomains.

Signaling Pathways

Hair Cell Signaling

While the exact signaling cascade is not fully characterized, clarin 1 participates in:

[@stereocilia]: Stereocilia development pathway: Through USH1 protein complex
[@plasma]: Plasma membrane organization: Tetraspanin-enriched microdomains
[@calcium]: Calcium signaling: May modulate calcium homeostasis

Retinal Signaling

In photoreceptor cells, clarin 1 may function in:

• Phototransduction cascade: Modulation of signaling
• Synaptic function: Ribbon synapse organization
• Protein trafficking: Delivery to outer segment

Animal Models

Knockout Mouse

• Ush3a/Clrn1 knockout: Progressive hearing loss
• Stereocilia: Initial formation normal, degeneration over time
• Retina: Slow progressive degeneration

Zebrafish

• clarin1 morphants: Hair cell defects in lateral line
• Rescue studies: Test therapeutic constructs

Therapeutic Strategies

Gene Therapy

• AAV vectors: Testing various serotypes
• Promoter selection: Hair cell-specific expression
• Delivery route: Inner ear injection

Pharmacological

Epidemiology

Prevalence

• Usher - Regional variations**: Higher in some populations (e.g., Finland)

Mutation Spectrum

• Common mutations: p.Y176X, p.R186X, p.W141X
• Missense variants: Often hypomorphic alleles
• Population-specific: Founder mutations in various groups

Future Directions

Research Priorities

• Mechanism elucidation: Complete signaling pathway understanding
• Biomarkers: Early detection markers for clinical trials
• Combined approaches: Gene therapy + neuroprotection

Clinical Trials

• Natural history studies: Ongoing to understand progression
• Therapeutic trials: Planning for gene therapy interventions
• [Allen Human Brain Atlas - CLARIN1](https://human.brain-map.org/microarray/search/show?search_term=CLARIN1)
• [Allen Cell Type Atlas - clarin1](https://celltypes.brain-map.org/)
• [Allen Mouse Brain Atlas - clarin1](https://mouse.brain-map.org/)

References

Unknown, Stereocilia development pathway: Through USH1 protein complex (n.d.)

Unknown, Plasma membrane organization: Tetraspanin-enriched microdomains (n.d.)

Unknown, Calcium signaling: May modulate calcium homeostasis (n.d.)